Latest Corporate & Commercial Updates

Latest Press releases

HalioDx Partners with DASA, the Largest Diagnostics Provider in Latin America, to make Immunoscore® available in Brazil

HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers, today announced...

 Read more

Distributors

Expanding Immunoscore® clinical utility on 3000+ stage III colon cancer patients

HalioDx SAS, the immuno-oncology diagnostic company pioneering the immunological diagnosis of cancers, today announced...

 Read more

IMMUNOSCORE® in Colon Cancer

New data reinforce Immunoscore® clinical utility in localized Colon Cancer

  • Changes in patterns of oncology care with the incorporation of immune response in a study of Stage II colon cancer...
 Read more

Paltown Development Foundation and HalioDx Team Up for Colorectal Cancer Testing Center

COLONTOWN University Launches Secure Platform for Colorectal Cancer Patients

HalioDx SAS, the immuno-oncology...

 Read more

IMMUNOSCORE® in Colon Cancer

Jérôme Galon has been awarded the French the Legion of Honor, or "Legion d'Honneur", received today from Gilles Bloch, Chairman and Chief Executive Officer of Inserm

Read more

HalioDx contribution to precision medicine at ESMO 2020

HalioDx SAS, the immuno-oncology diagnostic company, today announced that, at the European Society of Medical OncologyV...

 Read more

IMMUNOSCORE® IC in NSCLC

Immunoscore® to select patients in the POCHI trial, a phase II multicenter trial testing immunotherapy with chemotherapy and bevacizumab in metastatic colorectal cancer

HalioDx SAS, the immuno-oncology diagnostic company, today announced that it has entered into a Collaboration Agreement...

 Read more

IMMUNOSCORE® in Colon Cancer

Immunoscore® included in ESMO Clinical Practice Guidelines 2020

HalioDx SAS, the immuno-oncology diagnostic company, today announced that Immunoscore® has been included in the 2020...

 Read more

IMMUNOSCORE® in Colon Cancer

See more Press releases